HMC upgrades FY22 FFO Guidance to 29 cps

HMC Capital has announced upgraded FY22 pre-tax FFO guidance of 29.0 cps representing 121% growth on FY21, along with its FY22 half year results.

The six month period has been transformational for the Group with external AUM increasing to $5.2bn representing 280% growth on FY21. During the period the Group completed ~$3.5bn gross transactions and made a number of strategic hires to further expand our elite management team and capability. These hires will support our next wave of exciting growth initiatives. HMC also published its inaugural ESG report targeting scope 1 and 2 net zero emissions by 2028.

HMC Managing Director and CEO, David Di Pilla, said “1H FY22 was another transformational period for our group with ~$3.5bn of gross transactions including the successful acquisition of Aventus Group and the listing of HealthCo Healthcare and Wellness REIT. These highly strategic transactions will generate significant long-term value for shareholders and further demonstrate HMC’s ability to originate and execute large-scale transactions.”

“We have exceeded our $5bn FUM target 12 months ahead of our YE 2022 target, and we are on track to maintain that momentum and have the necessary capital, team and opportunity universe to reach our $10.0bn target well ahead of our target of 2024 year end target”

“Our ambition is to be Australia’s leading diversified alternative asset manager. Accordingly, we continue to invest in high quality talent to expand our elite management team and capability.”

To read our financial results, visit our investor centre.